Albareda N, Rosenberg N, Roth S, Zsolt I, Rosen T, Hebert AA. Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results. J of Skin [Internet]. 2017 Oct. 27 [cited 2024 Jul. 23];1(3.1):s102. Available from: https://jofskin.org/33014/index.php/skin/article/view/177